Weaker regulatory standards in the US can impact health everywhere.
Intuitively, it might seem desirable to speed up access to medicines. But this means more drugs will be approved that may subsequently prove unsafe or ineffective.
The author, center, and Dr. Anna Conti, left, and student Kelsey Parrish with Conti’s Basset hound, Picasso, who had surgery for cancer. Via Colorado State University.
William Cotton/CSU Photography
Dogs are great companions, and they also are proving to be great research subjects for cancer. Here's how our canine friends are pointing to possible treatments in human cancer.
President Barack Obama signs the 21st Century Cures Act on Tuesday, Dec. 13, 2016, in Washington.
Kevin Wolf/AP Images for Parker Foundation
Lowering the threshold for FDA approval and feeding the agency less rigorous information will increase the likelihood of approvals of unsafe or ineffective drugs and devices.
Once you start, you can’t stop.
'Injection' via www.shutterstock.com
By getting young women hooked before they've even formed wrinkles, Botox peddlers have realized they can enlist them in a lifetime of treatment.
There is conflicting medical evidence.
An injectable medication.
The maker of the EpiPen has raised the price of two injectable treatments to about US$600, six times the price nine years ago. Why do drug companies do this? Because they can. The FDA ends up helping.
Don’t touch that dough!
The FDA recently advised people not to eat raw cookie dough because raw flour with E. coli in it had sickened 38 people. Do we really have to forgo our favorites?
A sales clerk exhales vapor while smoking with a vaporizer during a wait for customers at the e-cigarette shop Henley Vaporium in New York.
Federal officials could give the FDA authority to develop e-cigarette regulations. But developing regulations that maximize their benefits and minimize their risks is harder than it looks.
Thalidomide was marketed as a safe, sleep-inducing drug, but when taken during pregnancy it could cause severe birth defects.
Documents reveal thalidomide's manufacturer was warned about possible harms as early as 1956.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached.
EPA/Erik S. Lesser
Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
found significant increases in harms with both the antidpressants used in Study 329, compared to the placebo.
As part of an intiative to re-examine misrepresented or abandoned studies, we re-analysed an antidepressant trial. Here's what we found.
The company that makes powdered alcohol says it will begin selling four different flavours this year.
The Victorian government is calling on other state governments to join it in banning powdered alcohol, which was recently approved for marketing and sale in the US.
Who pays for experimental treatments? Stock image from
In the last six months Colorado, Louisiana, Missouri, Michigan and, most recently, Arizona have passed “right to try” laws that allow terminally ill patients to access treatments that have only passed…
What if an experimental treatment seems to hold a terminal patient’s only hope?
Pill bottle image via www.shutterstock.com
On November 4, the state of Arizona will decide whether to join Colorado, Missouri, Louisiana and Michigan in passing so-called right to try laws. If passed, the “Arizona Terminal Patients’ Right To Try…
Ron Woodroof (played by Matthew McConaughey, right) changed HIV treatment in the US.
This article contains spoilers. In the award-winning movie The Dallas Buyers Club, Matthew McConaughey plays the role of Ron Woodroof, a real-life Texas cowboy who was diagnosed with HIV/AIDS in 1985…
Pills, spills and development aches.
Developing new drugs is hard and expensive. The lengthy process from initial discovery to the market is some times compared…
Signed, sealed, delivered, not yours.
Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or…
DNA peddling needs to be banned.
The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone…
Welcome to nowhere, says FDA.
Genetic testing is a powerful tool. Two years ago, with the help of my colleagues, it was this tool that helped us identify a new disease. The disease, called Ogden Syndrome, caused the death of a four-month…